Teva, Sanofi present new results from RELIEVE UCCD Phase 2b study
Teva Pharmaceuticals (TEVA), and Sanofi (SNY) presented new, detailed results from the RELIEVE UCCD Phase 2b study of duvakitug, a human IgG1-2 ...
Live Science on MSN1d
Why America is losing its 50-year 'war on cancer,' according to scientist Nafis Hasan
However, the nation has now been embroiled in this "war" for over 50 years, and we are nowhere closer to victory, argues ...
Guardant Health sues rival Natera over cancer-testing trade secrets
Medical diagnostics company Guardant Health has sued rival Natera in California federal court for allegedly stealing trade ...
WBUR2d
Judge extends temporary block to huge cuts in National Institutes of Health medical research funding
U.S. District Judge Angel Kelley had issued a temporary restraining order earlier this month in response to separate lawsuits filed by a group of 22 states — including Massachusetts — plus ...
Plaintiffs in Blue Cross antitrust settlement drop bid to disqualify law firm
Plaintiffs' lawyers who brokered a $2.8-billion antitrust settlement against Blue Cross Blue Shield have withdrawn their bid ...
MM&M3d
Rx Rundown: Moderna, Sanofi, GSK and more
Millie, a modern maternity clinic, secured $12 million in Series A funding led by existing investors RH Capital, TMV, ...